79 related articles for article (PubMed ID: 17334401)
1. Repression of intestinal drug metabolizing enzymes by the SV40 large T antigen.
Sáenz-Robles MT; Toma D; Cantalupo P; Zhou J; Gong H; Edwards C; Pipas JM; Xie W
Oncogene; 2007 Aug; 26(35):5124-31. PubMed ID: 17334401
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.
Martignoni M; Groothuis G; de Kanter R
Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor.
Kakizaki S; Yamazaki Y; Kosone T; Horiguchi N; Sohara N; Sato K; Takagi H; Yoshinari K; Mori M
Liver Int; 2007 Feb; 27(1):109-19. PubMed ID: 17241389
[TBL] [Abstract][Full Text] [Related]
4. SV40 rodent tumour models as paradigms of human disease: transgenic mouse models.
Furth PA
Dev Biol Stand; 1998; 94():281-7. PubMed ID: 9776248
[TBL] [Abstract][Full Text] [Related]
5. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment.
Meyer RP; Gehlhaus M; Schwab R; Bürck C; Knoth R; Hagemeyer CE
J Neurochem; 2009 Apr; 109(2):670-81. PubMed ID: 19226368
[TBL] [Abstract][Full Text] [Related]
6. Enterocyte proliferation and intestinal hyperplasia induced by simian virus 40 T antigen require a functional J domain.
Rathi AV; Sáenz Robles MT; Pipas JM
J Virol; 2007 Sep; 81(17):9481-9. PubMed ID: 17581980
[TBL] [Abstract][Full Text] [Related]
7. Transgenic model of smooth muscle cell cycle reentry: expression pattern of the collageneous matrix.
Sindermann JR; Köbbert C; Voss R; Ebbing J; March KL; Breithardt G; Weissen-Plenz G
Cardiovasc Pathol; 2008; 17(2):72-80. PubMed ID: 18329551
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
9. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic drugs affect neuronal androgen signaling via a cytochrome P450-dependent pathway.
Gehlhaus M; Schmitt N; Volk B; Meyer RP
J Pharmacol Exp Ther; 2007 Aug; 322(2):550-9. PubMed ID: 17505019
[TBL] [Abstract][Full Text] [Related]
11. [Biotransformation in occupational medicine: the role of hepatic cytochrome P-450 in the mechanism of action and the biological monitoring of occupational toxic compounds].
Manno M; Saia B
Med Lav; 1994; 85(1):11-21. PubMed ID: 8035741
[TBL] [Abstract][Full Text] [Related]
12. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
Bocchetta M; Eliasz S; De Marco MA; Rudzinski J; Zhang L; Carbone M
Cancer Res; 2008 Feb; 68(4):1022-9. PubMed ID: 18281476
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
14. [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
Guéguen Y; Mouzat K; Ferrari L; Tissandie E; Lobaccaro JM; Batt AM; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Souidi M
Ann Biol Clin (Paris); 2006; 64(6):535-48. PubMed ID: 17162257
[TBL] [Abstract][Full Text] [Related]
15. [Human drug metabolizing enzymes. I. Oxidative enzymes].
Vereczkey L; Monostory K; Veres Z
Acta Pharm Hung; 1998 Sep; 68(5):276-83. PubMed ID: 9805813
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.
Krishna DR; Shekar MS
Methods Find Exp Clin Pharmacol; 2005 Oct; 27(8):559-67. PubMed ID: 16273136
[TBL] [Abstract][Full Text] [Related]
17. Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters.
Glaeser H; Drescher S; van der Kuip H; Behrens C; Geick A; Burk O; Dent J; Somogyi A; Von Richter O; Griese EU; Eichelbaum M; Fromm MF
Clin Pharmacol Ther; 2002 Mar; 71(3):131-40. PubMed ID: 11907487
[TBL] [Abstract][Full Text] [Related]
18. Expression of SV40 T antigen gene in the oligodendroglia induced primitive neuroectodermal tumor-like tumors in the mouse brain.
Konishi S; Naora H; Kimura M; Sato M; Nagasaki M; Yokoyama M; Otani H; Moritake K; Katsuki M
Congenit Anom (Kyoto); 2004 Dec; 44(4):215-24. PubMed ID: 15566412
[TBL] [Abstract][Full Text] [Related]
19. Effect of SPG/indomethacin treatment on sepsis, interleukin-6 production, and expression of hepatic cytochrome P450 isoforms in differing strains of mice.
Saito M; Nameda S; Miura NN; Adachi Y; Ohno N
J Immunotoxicol; 2009 Mar; 6(1):42-8. PubMed ID: 19519162
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
Iyanagi T
Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
